Paper34501296
Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
Zapała Ł and 11 others. J Clin Med, 2021. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Papers, record 34501296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34501296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Publication subsidy fund | Warszawski Uniwersytet Medyczny | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17437789 | Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. | J Urol | 2007 | https://conductscience.org/library/papers/17437789 | PubMed |
| 2 | 28253496 | Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus. | Urol Int | 2017 | https://conductscience.org/library/papers/28253496 | PubMed |
| 3 | 28268170 | Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus. | J Urol | 2017 | https://conductscience.org/library/papers/28268170 | PubMed |
| 4 | 29035731 | Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study. | Transl Oncol | 2017 | https://conductscience.org/library/papers/29035731 | PubMed |
| 5 | 24752606 | Clinical management of renal cell carcinoma with venous tumor thrombus. | World J Urol | 2014 | https://conductscience.org/library/papers/24752606 | PubMed |
| 6 | 20471214 | Management of renal cell carcinoma with tumor thrombus in renal vein and the inferior vena cava. | Ann Vasc Surg | 2010 | https://conductscience.org/library/papers/20471214 | PubMed |
| 7 | 26421277 | Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26421277 | PubMed |
| 8 | 20980095 | Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. | Eur Urol | 2011 | https://conductscience.org/library/papers/20980095 | PubMed |
| 9 | 25650039 | Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience. | World J Surg Oncol | 2015 | https://conductscience.org/library/papers/25650039 | PubMed |
| 10 | 23849567 | Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system. | Int Braz J Urol | 2013 | https://conductscience.org/library/papers/23849567 | PubMed |
| 11 | 25817982 | Evaluation of perioperative complications in open and laparoscopic surgery for renal cell cancer with tumor thrombus involvement using the Clavien-Dindo classification. | Eur J Surg Oncol | 2015 | https://conductscience.org/library/papers/25817982 | PubMed |
| 12 | 30760245 | Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30760245 | PubMed |
| 13 | 29068785 | Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/29068785 | PubMed |
| 14 | 21640483 | Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. | Eur Urol | 2011 | https://conductscience.org/library/papers/21640483 | PubMed |
| 15 | 7653772 | Consistency of ASA grading. | Anaesthesia | 1995 | https://conductscience.org/library/papers/7653772 | PubMed |
| 16 | 29960124 | A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy. | Cancer Treat Rev | 2018 | https://conductscience.org/library/papers/29960124 | PubMed |
| 17 | 18692951 | Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. | Eur Urol | 2009 | https://conductscience.org/library/papers/18692951 | PubMed |
| 18 | 27562252 | Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. | J Surg Oncol | 2016 | https://conductscience.org/library/papers/27562252 | PubMed |
| 19 | 28111837 | Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor? | Int J Urol | 2017 | https://conductscience.org/library/papers/28111837 | PubMed |
| 20 | 24083566 | Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan. | BMC Cancer | 2013 | https://conductscience.org/library/papers/24083566 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39575426 | Machine learning-based multiparametric MRI radiomics nomogram for predicting WHO/ISUP nuclear grading of clear cell renal cell carcinoma. | Front Oncol | 2024 | https://conductscience.org/library/papers/39575426 | PubMed |
| 38106682 | Construction of the prognostic model in non-metastatic renal cancer patients with venous tumor thrombus. | Transl Androl Urol | 2023 | https://conductscience.org/library/papers/38106682 | PubMed |
| 36776325 | Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus. | Front Oncol | 2023 | https://conductscience.org/library/papers/36776325 | PubMed |
| 36386258 | Prognostic indicators for survival in renal cell carcinoma with venous thrombus and development of predictive nomograms. | Transl Androl Urol | 2022 | https://conductscience.org/library/papers/36386258 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34501296
GET https://conductscience.org/api/papers/v1/34501296/references?page=2